Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hirotatsu Nakaguchi"'
Autor:
Hirotatsu Nakaguchi, Yoshinobu Kondo, Mayu Kyohara, Hiromi Konishi, Koji Oiwa, Yasuo Terauchi
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 6, Pp 1542-1550 (2020)
Abstract Aims/Introduction Liraglutide and empagliflozin suppress cardiovascular events. However, reports on their long‐term combined use with insulin therapy or direct comparisons of these drugs are limited. Materials and Methods This open‐label
Externí odkaz:
https://doaj.org/article/c810c0ec5cb94520ae3dff807730d3cb
Autor:
Hiromi Konishi, Hirotatsu Nakaguchi, Koji Oiwa, Yoshinobu Kondo, Yasuo Terauchi, Mayu Kyohara
Publikováno v:
Journal of Diabetes Investigation
Journal of Diabetes Investigation, Vol 11, Iss 6, Pp 1542-1550 (2020)
Journal of Diabetes Investigation, Vol 11, Iss 6, Pp 1542-1550 (2020)
Aims/Introduction Liraglutide and empagliflozin suppress cardiovascular events. However, reports on their long‐term combined use with insulin therapy or direct comparisons of these drugs are limited. Materials and Methods This open‐label, paralle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06a32e4b081b2f78f2d67e29f74c83af
http://europepmc.org/articles/PMC7610130
http://europepmc.org/articles/PMC7610130
Publikováno v:
Diabetes. 68
Liraglutide (Lira) and empagliflozin (Empa) have been reported to suppress cardiovascular events in large-scale clinical trials. However, reports of their long-term combined use with insulin therapy or direct comparisons of both drugs are limited. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ce2fefde4c4121950147cbe3198b5c7
https://doi.org/10.2337/db19-113-lb
https://doi.org/10.2337/db19-113-lb
Autor:
Yosuke Miyaji, Yuichi Kawabata, Hideto Joki, Shunsuke Seki, Kentaro Mori, Tomoya Kamide, Akira Tamase, Hiroshi Shima, Motohiro Nomura, Yoshihisa Kitamura, Hirotatsu Nakaguchi, Taichi Minami, Tetsuji Tsunoda, Mayuko Sasaki, Masayo Yamada, Fumiaki Tanaka, Miyaji, Yosuke, Kawabata, Yuichi, Joki, Hideto, Seki, Shunsuke
Publikováno v:
BMC Neurology; 9/17/2016, Vol. 16, p1-6, 6p, 1 Diagram, 1 Chart
Autor:
Yuichi Kawabata, Yosuke Miyaji, Akira Tamase, Shunsuke Seki, Taichi Minami, Kentaro Mori, Masayo Yamada, Motohiro Nomura, Hideto Joki, Tomoya Kamide, Mayuko Sasaki, Hirotatsu Nakaguchi, Hiroshi Shima, Yoshihisa Kitamura, Fumiaki Tanaka, Tetsuji Tsunoda
Publikováno v:
BMC Neurology
Hypertension is the prime risk factor for stroke, and primary aldosteronism (PA) is the most common cause of secondary hypertension. The prevalence of PA in stroke patients has never been reported. The aim of this study was to elucidate the prevalenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14df376dfd13934b5ebd3f4f9e73eb99